Why the registry matters
Building Canada's most comprehensive bronchiectasis database
The Canadian Bronchiectasis and NTM Research Registry is a prospective observational study collecting clinical, imaging, and quality-of-life data from people with non-CF bronchiectasis and NTM infections across Canada.
Led by the University of Calgary and supported by national partners, BXConnect is designed to speed up study startup, recruit people who meet trial criteria faster, and give researchers a shared foundation for collaboration.
REB21-1131
Ethics Approval
Longitudinal follow-up
Annual updates
Study snapshot
Study ID
NCT06144996
Lead Institution
University of Calgary
Target Enrollment
2,000 participants
Timeline
2023 – 2050
Research Areas
Who we enroll
The registry is open to adults across Canada who have been diagnosed with non-CF bronchiectasis or NTM infections. By enrolling a diverse cohort of participants, we can better understand how these conditions affect different populations and identify patterns that may lead to improved treatments and care strategies.
Non-CF Bronchiectasis
Chronic airway widening and mucus retention leading to recurrent infections and reduced lung function.
Nontuberculous Mycobacteria (NTM)
Environmental mycobacterial infections often affecting people with bronchiectasis and requiring specialized treatment.